transforaminal epidural injection.
PreclinicalSmall molecule
transforaminal epidural injection. is one of 24 small molecule programs targeting Sciatica. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
23
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
27 competitors in Sciatica
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Aleve
Alnylam PharmaceuticalsApproved
Decadron
AAspen Global Incorporated
Approved
Oruvail
WWyeth-Lederle Vaccines
Approved
Advil
KKenvue Brands
Approved
Paracetamol
GSKApproved
Demerol
QQuagen
Approved
Vimpat
UCBPhase 3
Pred Forte
NovartisPhase 3
Rayos
RRoxane Laboratories
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Steroid Injection1 trial
Impact of Transforaminal Epidural Steroid Injection in Lumbar Disc Prolpse on Micro RNA-155 Serum Level
Completed·—·Phase 4·NCT05626283·88 enrolled
Treatment1 trial
Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor Necrotic Factor α Level
Completed·—·Phase 1·NCT05288920·80 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- EEduard Verheijen